Status:

UNKNOWN

Evaluation of MCM5 in Postmenopausal Bleeding Patients

Lead Sponsor:

Arquer Diagnostics Ltd

Conditions:

Endometrial Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

The objective of this multi-centre, prospective study, is to evaluate the performance of a urine MCM5 ELISA test (ADXGYNAE) in the detection of endometrial cancer in patients with postmenopausal bleed...

Eligibility Criteria

Inclusion

  • Patients 18 years of age or older
  • Patients who are at least 1 year post-menopausal i.e. have not had a menstrual period for at least one year
  • Patients who, in the opinion of the Investigator, are suitable for standard gynaecological investigations as part of normal clinical practice
  • Patients who are, in the opinion of the Investigator, able to understand the purpose of the study and provide a full void urine specimen
  • Patients who are able to give voluntary, written informed consent to participate in this study and from whom consent has been obtained

Exclusion

  • Patients with known symptomatic calculi within the urino-genitary system
  • Patients currently undergoing chemotherapy or radiotherapy
  • Patients who have previously been diagnosed with bladder or renal cancer who are currently in follow up
  • Patients with a medical contraindication to endometrial biopsy
  • Patients who do not wish to have an endometrial biopsy even if deemed necessary by the treating physician
  • Patients who have had urological instrumentation to the urinary tract within 14 days prior to the test (including catheterisation)
  • Patients who have had any gynaecological instrumentation in the previous 14 days

Key Trial Info

Start Date :

March 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2023

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT05287048

Start Date

March 1 2022

End Date

September 1 2023

Last Update

February 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Saint Mary's Hospital, Central Manchester NHS Foundation Trust

Manchester, United Kingdom, M13 9WL